Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
540 participants
OBSERVATIONAL
2023-12-22
2028-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Fluoroscopy Afib Ablation Registry
NCT02830750
Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation
NCT04954911
ABLATOR Ablation Observational Registry
NCT02344173
Atrial Fibrillation Ablation Registry
NCT03075930
Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)
NCT02433613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Arm
Patients enrolled and treated with the Affera Platform
Affera Platform
A cardiac ablation will be performed using the Affera Platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Affera Platform
A cardiac ablation will be performed using the Affera Platform
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned procedure using the commercially available Affera Platform
* Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Ablation Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel
Brussels, , Belgium
IKEM - Institut Klinické a Experimentální Medicíny
Prague, , Czechia
Nemocnice Na Homolce
Prague, , Czechia
Hôpital Haut-Lévêque - CHU de Bordeaux
Bordeaux, , France
Clinique Pasteur
Toulouse, , France
Charité Universitätsmedizin Berlin, DHZC - Campus Charité Mitte
Berlin, , Germany
MVZ CCB Frankfurt und Main Taunus GbR
Frankfurt, , Germany
Universitäres Herzzentrum
Hamburg, , Germany
Beacon Hospital
Dublin, , Ireland
Inselspital - Universitätsspital Bern
Bern, , Switzerland
Royal Papworth Hospital NHS Foundation Trust
Cambridge, , United Kingdom
Imperial College Healthcare NHS Trust - Hammersmith Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Affera Global Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.